Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Shah Rajeev M., Director. Officer active across 3 companies, notably Black Diamond Therapeutics, Inc.. Cumulatively, 3 reports have been logged. Activity tracked since 20 May 2021. The latest transaction was filed on 6 June 2023 (U). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Shah Rajeev M. is a Board Member at Black Diamond Therapeutics, Inc. and Kala Pharmaceuticals, Inc. He contributes to the governance of these companies by participating in strategic decision-making and overseeing operations. His experience in the pharmaceutical sector is an asset for the organizations.